Type to search…

Dual GLP-1/GIP agonist peptide for metabolic and glycaemic research. Supplied as lyophilized powder — bacteriostatic water required for reconstitution.
Tirzepatide is a dual-acting GLP-1/GIP receptor agonist extensively studied in glycaemic control and metabolic research. It is one of the first compounds to target both incretin pathways simultaneously.